Skip to main content (Press Enter).
A CEO's Perspective
President and CEO of AmerisourceBergen, Steve Collis, discusses the key trends affecting the pharmaceutical industry today including:
View part 2
Steve Collis is President and Chief Executive Officer of AmerisourceBergen Corporation. Mr. Collis previously served as President and Chief Operating Officer, responsible for all AmerisourceBergen business units including AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS), and AmerisourceBergen Packaging Group (ABPG). Previously, Mr. Collis was Executive Vice President of AmerisourceBergen and President of ABDC, the Company's largest subsidiary with revenues over $60 billion. During his tenure with the Company, Mr. Collis was the driving force behind growing and developing ABSG into the market-leader it is today, with $16 billion in annualized revenues.
Born and educated in South Africa, Mr. Collis earned a Bachelor of Commerce degree and a Bachelor of Commerce with Honors degree from the University of the Witwatersrand in Johannesburg.
AmerisourceBergen
Jan 10, 2012